MedWorld Advisors 11/17/25 MedWorld Advisors 11/17/25

Medical device regulatory pathways, reimbursement, and their impact on intrinsic value in MedTech

Device regulatory pathways, compliance strategies, and reimbursement models shape intrinsic value in medtech, influencing investors, valuations, and long-term growth.

MedWorld Advisors 11/6/25 MedWorld Advisors 11/6/25

JLL Partners Combines Vascular Technology Incorporated and Parks Medical Electronics; MedWorld Advisors Serves as Buy-Side Advisor

The combined leadership teams from Vascular Technology and Park Medical Electronics will drive the platform’s next phase of growth.

MedWorld Advisors 10/30/25 MedWorld Advisors 10/30/25

How the Top 30 MedTech Companies Are Shaping the Future

The MedTech Conference offered a live look at Top 30 companies’ priorities.

MedWorld Advisors 10/22/25 MedWorld Advisors 10/22/25

CDMOs: Dynamic Industry M&A Players Ready for Inorganic Growth

Today’s CDMOs are no longer support players; they are dealmakers, consolidators, and strategic partners.

MedWorld Advisors 10/15/25 MedWorld Advisors 10/15/25

What happens when your competitors start paying attention?

Innovation isn’t just about growth, it can also shape your exit strategy and attract the attention of strategic buyers.

MedWorld Advisors 10/13/25 MedWorld Advisors 10/13/25

Top 10 Companies: Insights from 2024 and What May Unfold in 2026

For 2026, the “podium” is safe, but the real sparks may fly in the mid- to bottom tier.

Estelle Black 9/29/25 Estelle Black 9/29/25

Part 2: What sellers need to know about due diligence in mergers and acquisitions

Maximize success with thorough due diligence in mergers and acquisitions for medtech businesses.

Estelle Black 9/23/25 Estelle Black 9/23/25

The Critical Role of AI in MedTech Supply Chain Management

Optimizing supply chain management is no longer a competitive advantage, but rather a necessity.

MedWorld Advisors 9/15/25 MedWorld Advisors 9/15/25

Preparing Your Business for a Sale

Is your business truly ready for a sale or outside investment? Manufacturing leaders need to think beyond short-term wins and start building long-term, transferable value, whether a business transition is around the corner or decades away.

MedWorld Advisors 9/10/25 MedWorld Advisors 9/10/25

Getting Due Diligence Right Prior to Selling Your Company—An MPO Videobites

Estelle Black of MedWorld Advisors shares her expertise and best practices to make selling a firm as smooth an experience as possible.

MedWorld Advisors 8/26/25 MedWorld Advisors 8/26/25

The ODT Top 10: Resilience, Reinvention, and the Road Ahead for Manufacturing Partnerships

Among the many dynamics impacting the industry is resilience—the key to success of any size OEM or supplier.

MedWorld Advisors 8/19/25 MedWorld Advisors 8/19/25

Why Emotional Intelligence Matters in Dealmaking

In any deal, emotions can run high. But letting them take over could cost you more than your cool—it could cost you the deal itself.

Daniel Sheppard 8/11/25 Daniel Sheppard 8/11/25

How the Medtech On-Shoring Boom is Redrawing the Supply Chain Map

We’re seeing real dollars, factory builds, acquisitions, and strategic shifts from the largest OEMs to mid-sized and even startup players.

Estelle Black 8/4/25 Estelle Black 8/4/25

Part 1: What sellers need to know about the due diligence process in an acquisition

Due diligence helps ensure the future of a partnership looks bright for all stakeholders. Part 1 of our Today’s Medical Developments Magazine article, we tell you what you need to know about this part of the acquisition process.

MedWorld Advisors 7/24/25 MedWorld Advisors 7/24/25

MedWorld Advisors Celebrates 10 Year Anniversary

Thank you to all who have been part of our journey! We look forward to continuing to support business owners in the healthcare space around the world.

Estelle Black 7/21/25 Estelle Black 7/21/25

2025 MedTech M&A Trend: Carve-outs and Divestitures

These transactions – where companies spin off, sell, or reallocate parts of their business – reshape portfolios, redefine priorities, and unlock value across the healthcare ecosystem.

MedWorld Advisors 7/17/25 MedWorld Advisors 7/17/25

Ortoma AB AI assisted technology helps cut pre-surgical planning time from weeks to minutes

Congratulations to our partners at Johnson & Johnson MedTech / DePuy Synthes and Ortoma AB on delivering this innovative technology to the market for the benefit of patient outcomes and all stakeholders involved.

MedWorld Advisors 7/1/25 MedWorld Advisors 7/1/25

JLL Partners Announces Investment in Vascular Technology, Incorporated

MedWorld Advisors serves as advisor to Vascular Technology, Inc, a medical device company specializing in innovative surgical devices and single-use consumables for the operating room, in their sale to middle market PE firm JLL Partners.

MedWorld Advisors 6/24/25 MedWorld Advisors 6/24/25

Driving growth and value in MedTech companies

Explore how MedTech companies can build long-term intrinsic value through market strategy, financial health, culture, and innovation.

MedWorld Advisors 6/16/25 MedWorld Advisors 6/16/25

Can MedTech M&A Provide a Solution to Tariffs?

As shown in past economic cycles, M&A will serve as an avenue to adapt to these changes and increase sustainability for businesses and customers alike.

Contact us.